image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendations

Anpario - Passes trough earnings (no pun intended)

January 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ANP
  • Price:
  • 375p
Anpario has grown into a leading player in the agritech sector with a “buy and build” strategy focused on developing and marketing natural feed additives used for improving the health and performance of production animals (chickens, pigs and dairy cows). Unlike traditional antibiotics and vaccines, these are non-pharmaceuticals, working to support the animal’s natural system by promoting gut health and significantly reducing the probability of animal illnesses and diseases, and also helping farmers achieve optimal performance (overall health and live weight) while increasing their return on investment (ROI) sustainably. Overusing antibiotics in farming has caused serious problems, like antimicrobial resistance, where bacteria then ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW